Arbutus Biopharma Corp (ABUS)

Arbutus Biopharma Corp (ABUS) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $648M; returns 1 day -0.2%, 1 week -0.5%, 1 year -1.9%.

Arbutus Biopharma Corp (ABUS) is a clinical-stage biopharmaceutical company primarily focused on developing a functional cure for chronic Hepatitis B virus (cHBV) infection, an area of significant unmet medical need affecting over 250 million people globally.

Groups ABUS belongs to

• Biotechnology
• Biopharmaceutical
• Clinical Stage
• Clinical Stage Biopharma
• Healthcare
• Antivirals
• Infectious Diseases
• Unmet Medical Needs
• Drug Discovery
• PD-L1

ABUS financial model: income statement, cash flow and balance sheet